Cart
sales@molnova.com
CRAC intermediate 1
CAS No. 1249343-86-9
CRAC intermediate 1( 5-(S)-Fluorowillardiine )
Catalog No. M26129 CAS No. 1249343-86-9
CRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | Get Quote |
|
| 5MG | 58 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 156 | Get Quote |
|
| 50MG | 259 | Get Quote |
|
| 100MG | 410 | Get Quote |
|
| 500MG | 888 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCRAC intermediate 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors.
-
DescriptionCRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors.
-
In Vitro——
-
In Vivo——
-
Synonyms5-(S)-Fluorowillardiine
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorAMPA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1249343-86-9
-
Formula Weight223.183
-
Molecular FormulaC10H7F2N3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 50 mg/mL (224.03 mM)
-
SMILESFc1cccc(F)c1C(=O)Nc1cc[nH]n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Arai AC, Kessler M, Rogers G, Lynch G. Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466. Mol Pharmacol. 2000 Oct;58(4):802-13. PubMed PMID: 10999951.
molnova catalog
related products
-
GSK205
GSK205 is a selective TRPV4 antagonist that blocks Ca(2+) signaling and may be used to reduce inflammation and pain.
-
Devapamil
Devapamil (Devapamilo) is a phenylalkylamine that blocks L-type calcium currents from the inner side of membrane cells in a use-dependent manner.
-
Upacicalcet
Upacicalcet (AJT-240) is an intraventricular calcium mimetic, a SHPT available for human hemodialysis, that inhibits excessive parathyroid hormone (PTH) secretion by directly acting on parathyroid cell membrane calcium-sensitive receptors, thereby lowering blood levels of PTH.
